Opposite influences of different adrenoceptors on baclofen-induced antinociception in mice

Pharmacology and Toxicology

Volumn 80, Issue 1, 1997, Pages 6-10

  Sabetkasai, M ^a   Doost Mohammady, R ^a   Zarrindast, M R ^b,c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; BACLOFEN; CLONIDINE; PHENOXYBENZAMINE; PHENYLEPHRINE; PRAZOSIN; PROPRANOLOL; RECEPTOR SUBTYPE; RESERPINE; YOHIMBINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0031032917     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1997.tb00276.x     Document Type: Article

References (27)

1. Andén, N. E. & H. Wachtel: Biochemical effects of baclofen (β-parachlorophenyl-GABA) on the dopamine and noradrenaline in the brain. Acta pharmacol. toxicol. 1977, 40, 310-320.
2. Bartolini, A., R. Malmberg, R. Bartolini & A. Giotti: Effect of antimigraine drugs on nonopioid analgesia. Adv. Neurol. 1982, 33, 89-97.
3. Bowery, N. G., D. R. Hill, A.L. Hudson, A. Doble, D. N. Middlemiss, J. Shaw & M. Turnbull: (-)-Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature 1980, 283, 92-94.
4. Bowery, N. G., A. Doble, D. R. Hill, A. L. Hudson, J. S. Shaw, M. J. Turnbull & R. Warrington: Bicuculline-insensitive GABA receptors on peripheral autonomic nerve terminals. Eur. J. Pharmacol. 1981, 71, 53-70.
5. Cutting, D. A. & C. C. Jordan: Alternative aproaches to analgesia: baclofen as a model compound. Brit. J. Pharmacol. 1975, 54, 171-179.
6. DaPrada, M. & H. H. Keller: Baclofen and y-butyrate: similar effects on cerebral dopamine neurons. Life Sci. 1976, 19, 1253-1264.
7. Enna, S. J.: GABA receptors. In: The GABA receptors Ed.: Enna S. J. Human Press. Clifton, New Jersey, 1983, pp. 1-23.
8. 3H-noradrenaline release from rat hippocampal synaptosomes. J. Physiol. 1983, 339, 39-40.
9. Fromm, G. H., C. F. Terrence & A. S. Chatha: Balcofen in the treatment of trigeminal neuralgia: Double blind study an long-term follow up. Ann. Neurol. 1984, 15, 240-244.
10. Gianutsos, G. & K. E. Moore: Tolerance to the effects of baclofen and y-butyrolactone on locomotor activity and dopaminergic neurons in the mouse. J. Pharmacol. Exp. Therap. 1979, 207, 859-869.
11. Guyenet, P. G. & G. K. Aghajanian: ACh, substance P and metenkephalin in the locus coeruleus: Pharmacological evidence for independent sites of action. Eur. J. Pharmacol. 1979, 53, 319-328.
12. B sites in rat brain. Nature 1981, 290, 149-152.
13. Hill, R. C., R. Maurer, H. H. Buescher & D. Roemer: Analgesic properties of the GABA-mimetic THIP. Eur. J. Pharmacol. 1981, 69, 221-224.
14. Hylden, J. K. L. & G. L. Wilcox: Pharmacological characterization of substance P-induced nociception in mice: Modulation by opioid and noradrenergic agonists at the spinal level. J. Pharmacol. Exp. Therap. 1983, 226, 398-404.
15. Levy, R. A. & H. K. Proudfit: The analgesic action of baclofen (b(4-chlorophenyl)-y-aminobutyric acid). J. Pharmacol. Exp. Therap. 1977, 202, 437-445.
16. Pinto, O. de S., M. Polikar & G. Debono: Results of international clinical trials witrh Lioresarl. Postgrad. Med. J. 1972, 48, Suppl. 5, 18-23.
17. Roerig, S. C., S., Lei, K., Kitto, J. K. L. Hylden, & G. L. Wilcox: Spinal interactions between opioid and noradrenergic agonists in mice: Multipilicity involves delta and alpha-2 receptors. J. Pharmacol. Exp. Therap. 1992, 262, 365-374.
18. Sabetkasai, M. & M. R. Zarrindast: Antinociception: interaction between adenosine and GABA systems. Arch. int. Pharmacodyn. 1993, 322, 14-22.
19. Sawynok, J.: Monoamines as mediators of the antinociceptive effect of baclofen. Naunyn-Schmiedebergs Arch. Pharmacol. 1983, 323, 54-57.
20. Sawynok, J.: GABAergic mechanisms of analgesia: an update. Pharmacol. Biochem. Behav. 1987, 26, 463-474.
21. Sawynok, J. & A. Reid: Clonidine reverses baclofen-induced increase in noradrenaline turnover in rat brain. Neurochem. Res. 1986, 11, 723-731.
22. B receptors to the noradrenergic system. J. Neural. Transm. 1985, 62, 77-89.
23. Tamayo, L., J. Reid & E. Contreras: Influences of adrenergic and cholinergic mechanism in baclofen induced analgesia. Gen. Pharmacol. 1988, 19, 87-89.
24. Young, R. R. & P. J. Delwaide: Drug therapy : Spasticity. New Engl. J. Med. 1981, 304, 96-99.
25. A antagonist and Baclofen analgesia. Gen. Pharmacol. 1989, 19, 703-706.
26. Zarrindast, M. R. & E. Moghadampour: Influences of dopamine agonists and antagonists on baclofen antinociception in mice. Arch. int. Pharmacodyn. 1991, 309, 42-50.
27. Zarrindast, M. R. & M. Sabetkasai: Stress-induced antinociception and GABAergic mechanism. Arch. int. Pharmacodyn. 1992, 318, 5-12.